Literature DB >> 23394391

NAT2 sequence polymorphisms and acetylation profiles in Indians.

Naazneen Khan1, Veena Pande, Aparup Das.   

Abstract

BACKGROUND: NAT2, a broad-spectrum drug-metabolizing gene, is of high pharmacogenetic interest. Based on seven different mutations in the NAT2 gene, an individual can either be categorized as a slow or fast acetylator. MATERIALS &
METHODS: In order to characterize acetylation profiles of Indians, where data are poorly available, we sequenced the 873 bp NAT2 coding region in 250 Indians, covering the whole of India including three tribes.
RESULTS: Altogether, 35 NAT2 alleles forming two acetylator phenotypes (distributed almost in equal proportion in India) were found; while the alleles determining slow acetylators were highly differentiated, the fast acetylator alleles were less in number but highly frequent.
CONCLUSION: Interestingly, distribution of two different acetylation phenotypes correlated well with historical dietary pattern in India. The neighbor-joining phylogenetic tree based on NAT2 gene polymorphisms in worldwide humans revealed genetic affinities among populations with similar acetylation phenotypes, which also placed Indians and Africans together in a single cluster.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23394391     DOI: 10.2217/pgs.13.2

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  7 in total

1.  N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.

Authors:  Azza M Kamel; Gamal T A Ebid; Heba S Moussa
Journal:  Tumour Biol       Date:  2015-03-25

2.  Can the personalized medicine approach contribute in controlling tuberculosis in general and India in particular?

Authors:  Nikhat Khan; Aparup Das
Journal:  Precis Clin Med       Date:  2020-06-04

Review 3.  Genetic Variants and Drug Efficacy in Tuberculosis: A Step toward Personalized Therapy.

Authors:  Almas Khan; Mohammad Abbas; Sushma Verma; Shrikant Verma; Aliya Abbas Rizvi; Fareya Haider; Syed Tasleem Raza; Farzana Mahdi
Journal:  Glob Med Genet       Date:  2022-02-25

Review 4.  PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.

Authors:  Ellen M McDonagh; Sotiria Boukouvala; Eleni Aklillu; David W Hein; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-08       Impact factor: 2.089

5.  Exploring the relationship between lifestyles, diets and genetic adaptations in humans.

Authors:  Cristina Valente; Luis Alvarez; Sarah J Marks; Ana M Lopez-Parra; Walther Parson; Ockie Oosthuizen; Erica Oosthuizen; António Amorim; Cristian Capelli; Eduardo Arroyo-Pardo; Leonor Gusmão; Maria J Prata
Journal:  BMC Genet       Date:  2015-05-28       Impact factor: 2.797

6.  N-acetyltransferase 2 (NAT2) gene polymorphism as a predisposing factor for phenytoin intoxication in tuberculous meningitis or tuberculoma patients having seizures - A pilot study.

Authors:  Prashant S Adole; Parampreet S Kharbanda; Sadhna Sharma
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

7.  NAT2 gene polymorphism: covert drug interaction causing phenytoin toxicity.

Authors:  C Adithan; A Subathra
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.